Possible Role of Ga-68 PSMA PET/CT in Evaluation of Systemic Treatment Response in Patients with Metastatic Prostate Cancer
Journal Title: Nükleer Tıp Seminerleri - Year 2018, Vol 4, Issue 3
Abstract
Despite the move toward molecular diagnostics, our clinical imaging paradigms for diagnosing cancer and for monitoring cancer therapy have largely remained at the anatomical rather than the cellular or molecular level. In order to monitor the response to treatment in prostate cancer, RECIST (Response Evaluation Criteria in Solid Tumors) criteria, which are based on anatomic size, are still used. Ga-68 prostate-specific membrane antigen (PSMA) has been introduced in 2012, but its use has been rapidly spread over the last 6 years. Ga-68 PSMA PET/CT imaging is an area of increasing interest and has taken over the traditional role of CT and bone scintigraphy in monitoring the chemotherapeutic response of patients with prostate cancer. There are some studies showing that the metabolic tumor parameters obtained by Ga-68 PSMA, such as whole-body PSMA tumour volume and whole-body total lesion PSMA, are promising compared to CT. Multimodel imaging combining morphological and molecular information is important not only for diagnostic accuracy but also for evaluating treatment response. However, prospective validation studies are required to elicit the full potential of metabolic parameters derived from Ga-68 PSMA PET/CT imaging and to adapt to the PERCIST criteria.
Authors and Affiliations
İlknur Ak Sivrikoz
Keywords
Related Articles
- EP ID EP421374
- DOI 10.4274/nts.2018.026
- Views 104
- Downloads 0
Imaging Modalities Used in Preclinical Studies
Imaging modalities have long been indispensable tool in clinical and preclinical practice or drug development. Increasingly, in vivo imaging of small laboratory animals has gained importance as a critical component of pr...
Possible Role of Ga-68 PSMA PET/CT in Evaluation of Systemic Treatment Response in Patients with Metastatic Prostate Cancer
Despite the move toward molecular diagnostics, our clinical imaging paradigms for diagnosing cancer and for monitoring cancer therapy have largely remained at the anatomical rather than the cellular or molecular level. I...
Patient and Personnel Radiation Exposure in Sentinel Lymph Node Practice
Sentinel lymph node imaging is the method used for regional staging most commonly in breast cancer, skin cancer, as well as head and neck cancer. Recently, it has also been used in gynecologic tumors. Detection of the se...
Systemic Therapy in Metastatic Castration-Resistant Prostate Cancer
Prostate cancer is the second leading cause of cancer death in men. Tumor growth and progression are androgen-dependent; for this reason, androgen deprivation therapy has been the main therapeutic intervention for treatm...
Radiation Detection and Measurement
Radiation is not a phenomenon that can be sensed, it is invisible, inaudible, imperceptible, and it cannot be perceived by contact. In cases of diagnosis, treatment, radiation protection, and possible radiation accidents...